Top Midday Gainers

MT Newswires Live

2024/08/06

Top Midday Gainers

TenX Keane Acquisition (TENK) shareholders approved the company's proposed merger with Citius Pharmaceuticals' (CTXR) oncology unit. The combined company will be renamed Citius Oncology Inc.

TenX shares skyrocketed 192% as intraday trading volume surged to over 1.3 million from a daily average of about 11,000.

Zevra Therapeutics (ZVRA) shares soared after the company said Friday that a US Food and Drug Administration advisory committee voted in favor of the data supporting arimoclomol as a treatment for patients with Niemann-Pick disease Type C, an inability of the body to transport cholesterol and other lipids within the cell.

Shares advanced 29% as intraday trading volume rose to over 7.4 million versus the stock's daily average of about 406,000.

Thoughtworks (TWKS) said Monday it entered into a definitive merger agreement in which an affiliate of funds advised by Apax Partners will buy all outstanding Thoughtworks common stock that they do not already own for $4.40 per share.

Shares rose 26% as intraday trading volume catapulted to more than 35.6 million from a daily average of about 797,000.

Price: 32.95, Change: +20.64, Percent Change: +167.67

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2457709631"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2457709631\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2457709631?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-08-06 01:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2457709631","market":"fut","top_or_hot":-1,"title":"Top Midday Gainers","media":"MT Newswires Live","content":"<html><body><p>Top Midday Gainers</p><p> <a href=\"https://laohu8.com/S/TENKU\">TenX Keane Acquisition</a> (TENK) shareholders approved the company's proposed merger with Citius Pharmaceuticals' (CTXR) oncology unit. The combined company will be renamed Citius Oncology Inc.</p><p>TenX shares skyrocketed 192% as intraday trading volume surged to over 1.3 million from a daily average of about 11,000.</p><p><a href=\"https://laohu8.com/S/ZVRA\">Zevra Therapeutics</a> (ZVRA) shares soared after the company said Friday that a US Food and Drug Administration advisory committee voted in favor of the data supporting arimoclomol as a treatment for patients with Niemann-Pick disease Type C, an inability of the body to transport cholesterol and other lipids within the cell.</p><p>Shares advanced 29% as intraday trading volume rose to over 7.4 million versus the stock's daily average of about 406,000.</p><p>Thoughtworks (TWKS) said Monday it entered into a definitive merger agreement in which an affiliate of funds advised by Apax Partners will buy all outstanding Thoughtworks common stock that they do not already own for $4.40 per share.</p><p>Shares rose 26% as intraday trading volume catapulted to more than 35.6 million from a daily average of about 797,000.</p><p>Price: 32.95, Change: +20.64, Percent Change: +167.67</p></body></html>","source":"mtnewswires_live","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-06 01:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Top Midday Gainers TenX Keane Acquisition (TENK) shareholders approved the company's proposed merger with Citius Pharmaceuticals' (CTXR) oncology unit. The combined company will be renamed Citius ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CTXR","symbol_name":"Citius Pharmaceuticals, Inc.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2457709631","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2457709631","pubTimestamp":1722880305,"columns":[],"sourceInfo":{"source_id":"mtnewswires_live","name":"MT Newswires Live"},"weMediaInfo":null,"summary":"Top Midday Gainers TenX Keane Acquisition (TENK) shareholders approved the company's proposed merger","collect":0,"end_time":0,"defaultTopTitle":"mtnewswires.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"CTXR":"Citius Pharmaceuticals, Inc.","TWKS":"Thoughtworks Holding Inc.","ZVRA":"Zevra Therapeutics","BK4134":"信息科技咨询与其它服务","BK4007":"制药"},"translate_title":"午盘涨幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TENK":1,"CTXR":1,"TWKS":1,"ZVRA":1},"content_text":"Top Midday Gainers TenX Keane Acquisition (TENK) shareholders approved the company's proposed merger with Citius Pharmaceuticals' (CTXR) oncology unit. The combined company will be renamed Citius Oncology Inc.TenX shares skyrocketed 192% as intraday trading volume surged to over 1.3 million from a daily average of about 11,000.Zevra Therapeutics (ZVRA) shares soared after the company said Friday that a US Food and Drug Administration advisory committee voted in favor of the data supporting arimoclomol as a treatment for patients with Niemann-Pick disease Type C, an inability of the body to transport cholesterol and other lipids within the cell.Shares advanced 29% as intraday trading volume rose to over 7.4 million versus the stock's daily average of about 406,000.Thoughtworks (TWKS) said Monday it entered into a definitive merger agreement in which an affiliate of funds advised by Apax Partners will buy all outstanding Thoughtworks common stock that they do not already own for $4.40 per share.Shares rose 26% as intraday trading volume catapulted to more than 35.6 million from a daily average of about 797,000.Price: 32.95, Change: +20.64, Percent Change: +167.67","kind":"live","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}